Loading chat...

TX SB1812

Bill

Official Source

Status

Introduced

3/3/2025

Primary Sponsor

Donna Campbell

Click for details

Origin

Senate

89th Legislature Regular Session

AI Summary

  • Adds neurodegenerative diseases to the list of conditions for which health insurers cannot require more than one prior authorization per year for prescription drugs

  • Expands existing prior authorization limits that currently apply to autoimmune diseases, hemophilia, and Von Willebrand disease

  • Applies to health benefit plans delivered, issued, or renewed on or after January 1, 2026

  • Takes effect September 1, 2025

Legislative Description

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

Health

Last Action

Referred to Health & Human Services

3/13/2025

Committee Referrals

Health & Human Services3/13/2025

Full Bill Text

No bill text available